Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi BiotecMiltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Links
Miltenyi Home
Tissue Dissociation
MACS Cell Separation
MACS Cell Analysis
Stem Cell Research
Neuroscience
Miltenyi Biotec
Disease biology
Defining disease 

Microarray-based analysis of inherited and acquired genomic variations, as well as transcriptional changes, allows for a deeper understanding of initiation and progression of disease.

Unravelling the biology of complex diseases, such as cancer, is a prerequisite for the development of new therapeutic interventions. The wealth of validated data sets that come from microarray analysis likely holds the information necessary to develop such approaches.
 
Several microarray studies have shown how valuable this technology is for the clear identification and characterization of disease, as initially described by Golub et al. (Science, 1999) and were further proven by numerous other studies, several of them based on data from our genomic service department (Wenzel et al., Int. J. Cancer, 2008).

Use our contact form to get in touch and to discuss your projects with our experts.
Miltenyi Biotec
Search this website
Advanced search
Services
Contact
Newsletter
Genomics Newsletter
Stay current with important developments subscribing to Genomic Services Newsletter.
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website